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Abstract
Although the association between high blood pressure (BP), particularly in midlife, and late-life 
dementia is known, less is known about variations by race and sex. In a prospective national study 
of 22,164 blacks and whites ≥45 years without baseline cognitive impairment or stroke from the 
Reasons for Geographic and Racial Differences in Stroke cohort enrolled 2003–2007 and followed 
through September 2015, we measured changes in cognition associated with baseline systolic and 
diastolic BP (SBP, DBP), as well as pulse pressure (PP) and mean arterial pressure (MAP), and we 
tested whether age, race, and sex modified the effects. Outcomes were global cognition (Six-Item 
Screener)(primary outcome)), new learning (Word List Learning), verbal memory (Word List 
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Delayed Recall), and executive function (Animal Fluency Test). Median follow-up was 8.1 years. 
Significantly faster declines in global cognition were associated with higher SBP, lower DBP, and 
higher PP with increasing age (P<0.001 for age*SBP* follow-up-time, age*DBP*follow-up-time, 
and age*PP*follow-up-time interaction). Declines in global cognition were not associated with 
MAP after adjusting for PP. Blacks, compared to whites, had faster declines in global cognition 
associated with SBP (P=0.02) and MAP (P=0.04). Men, compared to women, had faster declines 
in new learning associated with SBP (P=0.04). BP was not associated with decline of verbal 
memory and executive function, after controlling for the effect of age on cognitive trajectories. 
Significantly faster declines in global cognition over 8 years were associated with higher SBP, 
lower DBP, and higher PP with increasing age. SBP-related cognitive declines were greater in 
Blacks and men.
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INTRODUCTION
Cognitive impairment and dementia (CID) increases the risk of disability, burden of illness, 
and costs.1 CID affects about 8.6 million Americans2, a number expected to triple by 2050 
as the Baby Boomer generation ages3, with higher prevalence in Blacks compared with 
Whites and in women compared with men.4 The identification of modifiable risk factors that 
reduce disparities and prevent CID are top public health priorities.5 Exciting preliminary 
results from the SPRINT MIND trial show that high blood pressure (BP) is a modifiable risk 
factor to reduce CID risk.6
Although it is known that high BP, particularly in midlife, is associated with late-life CID7, 
less is known about variations by race and sex. Blacks are more likely to develop high BP 
and to have greater severity of high BP than Whites.8 Not only are Blacks more likely to 
have worse BP control than Whites9, but they also appear more likely to have detrimental 
brain effects from high BP10–13. A recent study14 suggests that Blacks have greater BP-
related cognitive declines; whereas, another study15 suggests that Whites do.
Gender differences in the association between BP and cognitive decline are less clear. Men 
are more likely than women to have high BP before age 50 but this disparity narrows and 
reverses at older ages. A recent study16 suggests that mid-life high BP increases late-life 
CID risk in women but not in men. It is uncertain whether the effect of high BP on late-life 
CID risk is greater in Blacks than in Whites or in women than in men, after accounting for 
the effect of age on the BP-cognition relationship17.
We assessed the association between systolic and diastolic BP (SBP and DBP) levels as well 
as levels of mean arterial pressure (MAP) and pulse pressure (PP) and cognitive trajectories 
over 8 years in a large, nationally representative cohort of middle-aged and older black and 
white adults, and tested whether race and sex modified the associations. We hypothesized 
that 1) higher SBP, lower DBP, and higher PP at baseline each are associated with faster 
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cognitive decline, and 2) that the effects of SBP and DBP on the slope of cognitive decline 
are greater in Blacks compared with Whites and in women compared with men.
METHODS
Study Design, Participants, and Measurements
Study protocol is available at http://www.regardsstudy.org/. Statistical code is available 
through written agreement with authors from Dr. Levine (e-mail: deblevin@umich.edu). 
Data set is available through a data use agreement with University of Alabama at 
Birmingham (e-mail: regardsadmin@uab.edu).The Reasons for Geographic and Racial 
Differences in Stroke (REGARDS) study is a prospective cohort study of 30,239 non-
Hispanic black and white individuals examining regional and racial influences on stroke 
mortality.18 Details are described elsewhere.18
Participants or their proxies were followed every 6 months by telephone with retrieval of 
medical records for reported hospitalizations. For this study, we followed participants 
through September 30, 2015. We required participants to have the first measurement of 
cognition by study design. We excluded participants with baseline cognitive impairment, 
defined as a Six-item Screener (SIS) score <5.19 We also excluded participants who self-
reported a baseline history of stroke or with an incident stroke before the first measurement 
of each cognitive outcome. The institutional review boards of all participating institutions 
approved the study and all participants provided written informed consent.
Cognitive Function Assessments
Trained REGARDS interviewers administered cognitive function tests longitudinally by 
telephone including: 1) the SIS (primary outcome; scores range 0–6) assessed global 
cognition annually beginning in 2003; and 2) a battery of 3 cognitive tests (secondary 
outcomes) measured biennially starting in 2006 that included the Consortium to Establish a 
Registry for Alzheimer’s Disease (CERAD) Word List Learning (WLL; new learning; 
scores range, 0–30), Word List Delayed Recall (WLD; verbal memory; scores range 0–10), 
and Animal Fluency Test (AFT); executive function; scores range >0).20, 21 These tests can 
be measured reliably and precisely over the telephone,22–24 are used in Vascular Cognitive 
Impairment Harmonization Standards,25 and have been validated in Blacks and Whites.19, 26
Measurement of Blood Pressure
At baseline, following a 5-minute rest, BP was measured twice in the left arm with a 
standard aneroid sphygmomanometer and the participant seated in a chair with 30 seconds 
between measurements.27 REGARDS uses the average of the two BP measurements. We 
centered BP at 120/80 mmHg because this was close to the mean BP for the study cohort 
and is considered normal BP.28 We excluded 1 participant with an extreme value of BP 
(diastolic BP ≤20; BP was 122/20) because this value is likely to be a result of incorrect 
measurement.
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Statistical Analysis
Each outcome measure was treated as a continuous variable and analyzed separately. Linear 
mixed-effects models measured changes in cognitive function over time by BP and included 
random effects for intercept and slopes as well as the covariates in Table 1. Time was 
expressed as the years from the date of the first measurement of each cognitive outcome. We 
rescaled the outcomes by dividing the cognitive scores by the standard deviation (SD) of the 
distribution of the baseline cognitive measurement of each test to facilitate interpretation. 
For each outcome, all available cognitive observations were used in the analysis except 
observations after the time of first expert-adjudicated incident stroke during follow-up 
because we have previously shown that incident stroke alters the intercept and trajectory of 
cognition.29 To examine assumptions of linear mixed effects models, e.g. linearity of the 
studied relationships and normality of residual errors we inspected residual plots. There was 
no evidence of non-linear effects of SBP or DBP on cognitive slopes.
To test the effect of baseline BP on the slopes of cognitive trajectories (first hypothesis), 
Model A included SBP*follow up time and DBP*follow up time interaction terms as well as 
SBP, DBP, follow up time, and covariates (Table 1 and online-only Data Supplement). We 
examined whether age17 and hypertension treatment status30 modified the effect of BP level 
on the slopes of cognitive trajectories (e.g., by investigating age*SBP*follow up time and 
age*DBP*follow up time interaction terms). To test whether race and sex modified the effect 
of BP level on the slopes of cognitive trajectories (second hypothesis), Model B added 
race*BP*follow up time and sex*BP*follow up time interaction terms to Model A. We 
stratified the data by age at baseline (45–64 versus ≥65 years) and fitted Model B for the 
primary outcome, Six-Item Screener. The parameter estimates from the age-stratified 
analyses were similar to the parameter estimates from the analysis of all ages (data not 
shown) so we present the results from the total sample.
We also performed analyses replacing SBP and DBP with mean arterial pressure (MAP) 
[((DBP x 2) + SBP)/3] and pulse pressure (PP) [SBP – DBP]. We calculated participant-
specific predicted values for each cognitive score over time for an exemplar subject, i.e., a 
75 year-old residing in the Stroke Belt with typical values of all covariates Slopes of 
cognitive decline were estimated for 20-mmHg differences in SBP and 10-mmHg 
differences in DBP.31 We also estimated the difference in predicted cognitive scores for 
different BPs (SBP: 160 mmHg vs 120 mmHg; DBP 60 mmHg vs 80 mmHg) at different 
intervals (study time 0 vs year 8, the median follow-up time) for the exemplar subject.
Statistical significance for all analyses was set as P<0.05 (two-sided). We performed all 
analyses using STATA version 14.2 (Stata Corporation, College Station, TX).
RESULTS
The study sample included 22,164 participants. Median follow-up was 8.1 years 
(interquartile range, 5.0–10.1 years). Follow-up time was 7.4 years in the 13,670 white 
participants and 6.8 years in the 8,494 black participants (absolute difference, 0.63 years 
[95% CI, 0.54 years to 0.72 years]; P<0.001). Follow-up time was 7.2 years in the 12,436 
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female participants and 7.1 years in the 9,728 male participants (absolute difference, 0.05 
years [95% CI, −0.04 years to 0.13 years]; P=0.3).
Figure I in the online-only Data Supplement presents derivation of cohort. Table I in the 
online-only Data Supplement presents baseline characteristics of study participants. Mean 
age was 64.2 (SD, 9.2) years, mean SBP was 127 (SD, 16) mmHg, and mean DBP was 76 
(SD, 10) mmHg. Of the 22,164 participants, 849 had incident stroke (727 ischemic, 78 
hemorrhagic, and 44 of undeterminable type) during follow-up. The frequency of incident 
stroke did not differ by race (521 strokes [3.8%] in whites and 328 [3.9%] strokes in blacks 
[absolute difference, 0.05%;95% CI, −0.4% to 0.5%; P = 0.85]) but was greater in men 
compared with women (428 [4.4%] strokes in men and 421 [3.4%] strokes in women 
[absolute difference, 1.0%; 95% CI, 0.5% to 1.5%; P<0.001]).
Participants had a median of 7 SIS tests (IQR, 4–10 tests) and a median of two 3-test 
batteries (IQR, 2–4 tests). Because the secondary outcome measures were introduced during 
follow-up and performed less frequently, the WLL analysis included 12,178 participants, the 
WLD analysis included 11,984 participants, and the AFT analysis included 12,902 
participants.
Change in Global Cognition associated with BP, Race, and Sex
Age significantly modified the effect of SBP, DBP, and PP levels, but not MAP, on the slope 
of global cognition trajectories (P<0.001 for age*SBP*follow up time interaction, P<0.001 
for age*DBP*follow up time interaction, P<0.001 for age*PP*follow up time interaction, 
and P=0.26 for age*MAP*follow up time interaction)(Model A for SBP/DBP and PP/MAP, 
Table 1). With increasing age, higher SBP, lower DBP, and higher PP were each associated 
with faster declines in global cognition. The effect of SBP and DBP on the slope of global 
cognition trajectories was not significantly different by hypertension treatment status 
(P=0.53 for hypertension treatment*SBP*follow up time interaction and P=0.26 for 
hypertension treatment*DBP*follow up time interaction).
In models replacing SBP and DBP with PP and MAP, PP (P<0.001), but not MAP (P=0.23), 
was significantly associated with changes in global cognition (Model A for PP and MAP, 
Table 1). Independent of MAP, higher PP was associated with significantly faster declines in 
global cognition controlling for age.
Blacks had significantly faster declines in global cognition associated with SBP compared to 
Whites (P=0.02 for race*SBP*follow up time interaction); but, race did not modify the 
effect of DBP on the slope of global cognition (P=0.79 for race*DBP*follow up time 
interaction) (Model B for SBP and DBP, Table 1). Black race also modified the effect of 
MAP on the slope of global cognition (P=0.04 for race*MAP*follow up time interaction) 
but not the effect of PP (P=0.22 for RACE*PP*follow up time interaction) (Model B for PP 
and MAP, Table 1). Blacks, compared to Whites, had significantly faster declines in global 
cognition associated with higher MAP. The effect of BP on the slope of global cognition 
trajectories was not significantly different by sex (P=0.23 for sex*SBP* follow up time 
interaction, P=0.57 for sex*DBP* follow up time interaction, P=0.31 for sex*PP* follow up 
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time interaction and P=0.86 for sex*MAP*follow up time interaction) (Model B for 
SBP/DBP and PP/MAP, Table 1).
We illustrate results of Models B using slope estimates of global cognition changes by age, 
race, sex, and the 4 BP measures (SBP, DBP, PP, and MAP) and by calculating participant-
specific predicted values of cognition (Table 2). Black women age 75 with common values 
of all covariates, compared with white women, had faster declines in global cognition 
associated with higher SBPs by 0.012 SD points-per-year-per 20 mmHg-increase (95% CI, 
0.002 to 0.022; p=0.02). Declines in global cognition associated with lower DBPs were 
similar in black women (decrease in slope: 0.015 SD points-per-year-per-10 mmHg-decrease 
[95% CI, 0.005 to 0.024; P=0.002]) and white women (decrease in slope: 0.016 SD points-
per-year-per-10 mmHg-decrease [95% CI, 0.008 to 0.024; P<0.001]) (Table 2). Figure 1 
shows slopes of global cognition by SBP, race, and sex (DBP fixed at 80 mmHg). Figure 2 
shows slopes of global cognition by DBP, race, and sex (SBP fixed at 120 mmHg). At age 
75, the difference in global cognition at year 8 was significantly greater than that at year 0 
for baseline SBP 160 vs. 120 mmHg (difference of difference for white women: −0.12 
points [95% CI, −0.05 to −0.19]; P<0.001) and non-significantly greater for baseline DBP 
60 vs. 80 mmHg (difference of difference: −0.05 points [95% CI, −0.11 to 0.01]; P=0.08).
Changes in New Learning, Verbal Memory, and Executive Function associated with BP, 
Race, and Sex
Higher SBP, lower DBP, and higher PP were significantly associated with faster declines in 
new learning, verbal memory, and executive function in partially adjusted models that did 
not include the effect of age on cognitive slopes (age*follow up time interaction) (Tables II 
and III in online-only Data Supplement). However, the effects of SBP, DBP, and PP on the 
slopes of these cognitive functions did not remain significant after further adjustment for the 
age-by-time interaction effect except men, compared to women, had faster declines in new 
learning associated with SBP (P=0.04)(Tables IV and V in online-only Data Supplement).
Sensitivity Analyses
Results were similar in analyses imputing missing values of baseline covariates, adjusting 
for death, adding history of myocardial infarction and GFR to models, and in analyses 
limited to participants with ≥2 follow-up cognitive measures (Tables VI and IX in online-
only Data Supplement).
DISCUSSION
In this national cohort of black and white Americans 45 years or older, faster declines in 
global cognition were associated with higher SBP, lower DBP, and higher PP in older adults. 
Faster declines in global cognition were associated with higher SBP and lower DBP as well 
as higher PP but not MAP. Blacks, compared to whites, had faster declines in global 
cognition associated with SBP and MAP. Men, compared to women, had faster declines in 
new learning associated with SBP. BP was not associated with slopes of verbal memory and 
executive function, after controlling for the effect of age on cognitive trajectories.
Levine et al. Page 6
Hypertension. Author manuscript; available in PMC 2020 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Our data suggest that BP-related cognitive declines are greater in Blacks compared with 
Whites and in men compared with women. Our results are consistent with a recent study14 
of older adults showing that Blacks, compared with Whites, have faster cognitive declines 
associated with high BP. Some studies have suggested that the effect of high BP on CID risk 
is greater in Whites compared with Blacks15 and in women compared with men16, 32, 33. Our 
results may differ because we used different cognitive measures, we studied older adults, 
and we controlled for the age-dependent effect of BP on cognition17. The results of the 
analysis of secondary outcomes may differ from those of the SIS because the former have 
fewer observations, longer measurement intervals, and reduced statistical power.
The declines in global cognition associated with high SBP and low DBP in older adults are 
likely clinically meaningful. Declines of ≥0.5 standard deviations (SD) from baseline have 
been defined as clinically meaningful decline34 and are correlated with clinically meaningful 
decline in adults with normal cognition and dementia.35, 36 A 0.5-SD decrease from the 
baseline score is approximately 0.2 points for the SIS. The 95% confidence intervals for the 
8-year differences in global cognition for baseline SBP of 160 compared with that of 120 
mmHg for exemplar individuals aged 75 or older include declines of this magnitude or 
approach them for white women (95% CI, 0.05 to 0.19). Declines in global cognition 
significantly increase the risk of death, dementia, and functional decline.19, 37–39
High or low BP may cause cognitive decline through several mechanisms. Hypertension 
may cause ongoing inflammation, oxidative stress, and cerebrovascular injury.40 Although 
we excluded cognitive measures occurring after the time of clinically apparent stroke, 
hypertension may cause subclinical vascular brain injury and damage to white matter 
integrity that contribute to subsequent cognitive decline.41, 42 Hypertension may also induce 
or exacerbate neurodegenerative disease.43, 44 Low BP may cause cognitive decline due to 
cerebral hypoperfusion. Blacks and men may be more likely to have detrimental brain 
effects from high BP because of early age of onset of high BP and worse BP control over the 
life course leading to greater arterial stiffness and more severe atherosclerosis10–13. Our data 
suggest a scientific need to determine how the timing, duration, and intensity of BP lowering 
interventions over the life course as well as race and sex influence the risk of cognitive 
decline.
Our study has several strengths. We had longitudinal cognitive assessments in a cohort of 
sufficient size to estimate BP-related changes in cognitive decline and to examine potential 
effect modification by race, sex, age, and hypertension treatment. REGARDS systematically 
measured cognitive domains commonly affected by vascular factors like hypertension: 
global cognition, learning, memory, and executive function.25 We had repeated measures 
over time up to 14 years of follow-up.
Our study has limitations. Results are generalizable only to community-dwelling adults not 
requiring a proxy respondent. Although excluded participants had higher prevalence of 
dementia risk factors than included participants, these differences would reduce the ability to 
detect the cognitive effects of BP. BP was measured only at baseline. Although selective 
attrition may lead to underestimation of cognitive decline because participants with worse 
cognition at baseline or during follow-up die, drop out, or require a proxy, analyses that 
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accounted for loss to follow-up or death did not change our results, consistent with prior 
research.45 Fewer cognitive observations potentially limited statistical power to detect 
associations between BP and the secondary outcomes. The slight increases in global 
cognition, new learning, and verbal memory over time may be due to selective attrition of 
cognitively impaired participants and practice effects associated with repeated testing.46, 47 
We did not have data on functional impairments, brain imaging, daily medication use or 
incident dementia.
Our study has clinical and policy implications. Preliminary results of the SPRINT MIND 
trial suggest that aggressive lowering of SBP reduces CID risk in older adults at high 
cardiovascular risk.6 Our results extend this work by suggesting that treatment of high SBP 
will reduce CID risk in a broader population of older adults, particularly Blacks and men. 
Our results also suggest that avoidance of low DBP is important to prevent cognitive decline 
in older adults. This is clinically important because SBP tends to increase and DBP tends to 
decrease as adults age. Blacks are more likely to have worse BP control than Whites. Our 
results suggest that eliminating the Black-White disparity in BP control has the potential to 
reduce racial disparities in CID risk. Our data also show that failure to account for the effect 
of age on cognitive slopes can overestimate the effect of BP on cognitive slopes and even 
cause a spurious association between BP and cognitive decline. Moreover, our results 
suggest that PP rather than MAP is a potential target for preventing CID.
PERSPECTIVES
Faster declines in global cognition over 8 years were associated with higher SBP, lower 
DBP, and higher PP in older adults. SBP-related cognitive declines were greater in Blacks 
and men. Our results suggest that blood pressure may contribute to Black-White disparities 
in CID risk.
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Novelty and Significance:
What Is New?
• It is unclear whether hypertension contributes to racial/ethnic and sex 
differences in dementia risk.
• We assessed the association between blood pressure (BP) levels and cognitive 
trajectories over 8 years and tested whether race and sex modified the 
associations, in a large, nationally representative cohort of middle-aged and 
older black and white adults.
• Our results suggest that lowering systolic BP in older adults, particularly 
Blacks and men, will reduce dementia risk. This is critical because Blacks 
have double the risk of dementia as Whites.
What Is Relevant?
• Hypertension is a modifiable risk factor associated with late-life dementia.
Summary: Higher systolic BP, lower diastolic BP, and higher pulse pressure were 
associated with faster declines in global cognition over 8 years in older adults. Systolic 
BP-related cognitive declines were greater in Blacks and men.
Levine et al. Page 12
Hypertension. Author manuscript; available in PMC 2020 February 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1: Conditional Predicted Values of Global Cognition over Time by Baseline Systolic Blood 
Pressure, Race, and Sex: REGARDS Study, 2003–2013
Participant-specific predicted values of global cognition were calculated for 75 year-old 
adults with the common values of all covariates at baseline (college education, stroke belt 
residence, income $20,000-$34,999, never smoker, no alcohol use, no diabetes, no 
hypertension treatment, waist circumference 95 cm, overweight BMI, 4-item CES-D score 
of 0.9 points, and fair health status) and Model B. Global cognition was measured by Six-
Item Screener. Six-Item Screener scores range 0 to 6 with higher scores indicating better 
performance. Diastolic blood pressure (BP) is fixed at 80 mmHg. The brown line indicates 
the slopes for participants with systolic BP of 110 mmHg. The green line indicates the 
slopes for participants with systolic BP of 120 mmHg. The blue line indicates the slopes for 
participants with systolic BP of 130 mmHg. The black line indicates the slopes for 
participants with systolic BP of 140 mmHg. The red line indicates the slopes for participants 
with systolic BP of 150 mmHg.
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Figure 2: Conditional Predicted Values of Global Cognition over Time by Baseline Diastolic 
Blood Pressure, Race, and Sex: REGARDS Study, 2003–2013
Participant-specific predicted values of global cognition were calculated for 75 year-old 
adults with the common values of all covariates at baseline (college education, stroke belt 
residence, income $20,000-$34,999, never smoker, no alcohol use, no diabetes, no 
hypertension treatment, waist circumference 95 cm, overweight BMI, 4-item CES-D score 
of 0.9 points, and fair health status) and Model B. Global cognition was measured by Six-
Item Screener. Six-Item Screener scores range 0 to 6 with higher scores indicating better 
performance. Systolic blood pressure (BP) is fixed at 120 mmHg. The brown line indicates 
the slopes for participants with diastolic BP of 70 mmHg. The green line indicates the slopes 
for participants with diastolic BP of 80 mmHg. The blue line indicated the slopes for 
participants with diastolic BP of 90 mmHg. The black line indicates the slopes for 
participants with diastolic BP of 100 mmHg. The red line indicates the slopes for 
participants with diastolic BP of 110 mmHg.
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